{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T21:58:17Z","timestamp":1767650297448,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100023985","name":"Office of Mental Health - Suicide Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100023985","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.josat.2023.209175","type":"journal-article","created":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T17:50:02Z","timestamp":1695577802000},"page":"209175","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Impact of an intervention to implement provision of opioid use disorder medication among patients with and without co-occurring substance use disorders"],"prefix":"10.1016","volume":"155","author":[{"given":"Madeline C.","family":"Frost","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol A.","family":"Malte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric J.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph E.","family":"Glass","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin A.","family":"Hallgren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily C.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2023.209175_bb0005","series-title":"National Center for Health Statistics","article-title":"Provisional drug overdose death counts","author":"Ahmad","year":"2023"},{"author":"American Society of Addiction Medicine","key":"10.1016\/j.josat.2023.209175_bb0010"},{"issue":"Suppl. 3","key":"10.1016\/j.josat.2023.209175_bb0015","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1007\/s11606-020-06260-9","article-title":"A research agenda for advancing strategies to improve opioid safety: Findings from a VHA state of the art conference","volume":"35","author":"Becker","year":"2020","journal-title":"Journal of General Internal Medicine"},{"issue":"Suppl 9 Suppl 2","key":"10.1016\/j.josat.2023.209175_bb0020","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1097\/MLR.0000000000000731","article-title":"Clinical epidemiology of single versus multiple substance use disorders: Polysubstance use disorder","volume":"55","author":"Bhalla","year":"2017","journal-title":"Medical Care"},{"issue":"1","key":"10.1016\/j.josat.2023.209175_bb0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13722-021-00218-w","article-title":"PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: A pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder treatment","volume":"16","author":"Campbell","year":"2021","journal-title":"Addiction Science & Clinical Practice"},{"issue":"11","key":"10.1016\/j.josat.2023.209175_bb0030","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index","volume":"47","author":"Charlson","year":"1994","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1016\/j.josat.2023.209175_bb0035","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2105\/AJPH.2019.305412","article-title":"Polysubstance use: A broader understanding of substance use during the opioid crisis","volume":"110","author":"Cicero","year":"2020","journal-title":"American Journal of Public Health"},{"author":"Department of Veterans Affairs","key":"10.1016\/j.josat.2023.209175_bb0040"},{"issue":"2","key":"10.1016\/j.josat.2023.209175_bb0045","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1097\/ADM.0000000000000719","article-title":"Disparities in access to medications for opioid use disorder in the veterans health administration","volume":"15","author":"Finlay","year":"2021","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.josat.2023.209175_bb0050","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13722-023-00382-1","article-title":"Treating opioid use disorder in veterans with co-occurring substance use: A qualitative study with buprenorphine providers in primary care, mental health, and pain settings","volume":"18","author":"Frost","year":"2023","journal-title":"Addict. Sci. Clin. Pract."},{"issue":"3","key":"10.1016\/j.josat.2023.209175_bb0055","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1080\/08897077.2020.1787299","article-title":"Stepped Care for Opioid Use Disorder Train the trainer (SCOUTT) initiative: Expanding access to medication treatment for opioid use disorder within Veterans Health Administration facilities","volume":"41","author":"Gordon","year":"2020","journal-title":"Substance Abuse"},{"issue":"8","key":"10.1016\/j.josat.2023.209175_bb0060","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamapsychiatry.2015.0584","article-title":"Epidemiology of DSM-5 alcohol use disorder: Results from the National Epidemiologic Survey on alcohol and related conditions III","volume":"72","author":"Grant","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.josat.2023.209175_bb0065","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jamapsychiatry.2015.2132","article-title":"Epidemiology of DSM-5 drug use disorder: Results from the National Epidemiologic Survey on alcohol and related conditions-III","volume":"73","author":"Grant","year":"2016","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.josat.2023.209175_bb0070","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13722-018-0127-z","article-title":"Advancing pharmacological treatments for opioid use disorder (ADaPT-OUD): Protocol for testing a novel strategy to improve implementation of medication-assisted treatment for veterans with opioid use disorders in low-performing facilities","volume":"13","author":"Hagedorn","year":"2018","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.josat.2023.209175_bb0075","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.drugalcdep.2019.01.031","article-title":"Polydrug use disorders in individuals with opioid use disorder","volume":"198","author":"Hassan","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"issue":"12","key":"10.1016\/j.josat.2023.209175_bb0080","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.37238","article-title":"Accessibility to medication for opioid use disorder after interventions to improve prescribing among nonaddiction clinics in the US veterans health care system","volume":"4","author":"Hawkins","year":"2021","journal-title":"JAMA Network Open"},{"author":"Hedegaard","key":"10.1016\/j.josat.2023.209175_bb0085"},{"key":"10.1016\/j.josat.2023.209175_bb0090","doi-asserted-by":"crossref","first-page":"108791","DOI":"10.1016\/j.drugalcdep.2021.108791","article-title":"Prevalence of substance use and substance-related disorders among US Veterans Health Administration patients","volume":"225","author":"Hoggatt","year":"2021","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.josat.2023.209175_bb0095","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1097\/ADM.0000000000000360","article-title":"Physicians\u2019 decision-making when implementing buprenorphine with new patients: Conjoint analyses of data from a cohort of current prescribers","volume":"12","author":"Knudsen","year":"2018","journal-title":"Journal of Addiction Medicine"},{"issue":"4","key":"10.1016\/j.josat.2023.209175_bb0100","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2149","article-title":"Primary care-based models for the treatment of opioid use disorder: A scoping review","volume":"166","author":"Korthuis","year":"2017","journal-title":"Annals of Internal Medicine"},{"issue":"9","key":"10.1016\/j.josat.2023.209175_bb0105","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/add.14991","article-title":"Opioid agonist treatment and fatal overdose risk in a state-wide US population receiving opioid use disorder services","volume":"115","author":"Krawczyk","year":"2020","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.josat.2023.209175_bb0110","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1097\/PHH.0000000000001168","article-title":"Structural racism and the opioid overdose epidemic: The need for antiracist public health practice","volume":"26","author":"Kunins","year":"2020","journal-title":"Journal of Public Health Management and Practice"},{"key":"10.1016\/j.josat.2023.209175_bb0115","doi-asserted-by":"crossref","first-page":"107732","DOI":"10.1016\/j.drugalcdep.2019.107732","article-title":"Prevalence and treatment of opioid use disorders among primary care patients in six health systems","volume":"207","author":"Lapham","year":"2020","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.josat.2023.209175_bb0120","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/add.15116","article-title":"Polysubstance use and association with opioid use disorder treatment in the US Veterans Health Administration","volume":"116","author":"Lin","year":"2021","journal-title":"Addiction"},{"issue":"6","key":"10.1016\/j.josat.2023.209175_bb0125","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1093\/ije\/dyy135","article-title":"The use of controls in interrupted time series studies of public health interventions","volume":"47","author":"Lopez Bernal","year":"2018","journal-title":"International Journal of Epidemiology"},{"issue":"6","key":"10.1016\/j.josat.2023.209175_bb0130","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/ajad.12553","article-title":"Three-year retention in buprenorphine treatment for opioid use disorder nationally in the Veterans Health Administration","volume":"26","author":"Manhapra","year":"2017","journal-title":"American Journal on Addictions"},{"issue":"1","key":"10.1016\/j.josat.2023.209175_bb0135","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/add.15229","article-title":"Commentary on Lin et al.: Saving lives during the opioid crisis-widening the focus from opioid use disorder to polysubstance use disorder and to multimorbidity","volume":"116","author":"Manhapra","year":"2021","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.josat.2023.209175_bb0140","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1080\/08897077.2019.1640831","article-title":"Initiating opioid agonist treatment for opioid use disorder nationally in the Veterans Health Administration: Who gets what?","volume":"41","author":"Manhapra","year":"2020","journal-title":"Substance Abuse"},{"key":"10.1016\/j.josat.2023.209175_bb0145","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jsat.2019.07.013","article-title":"Implementation of the hub and spoke model for opioid use disorders in California: Rationale, design and anticipated impact","volume":"108","author":"Miele","year":"2020","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.josat.2023.209175_bb0150","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jsat.2013.09.003","article-title":"Determinants of buprenorphine treatment for opioid dependence","volume":"46","author":"Murphy","year":"2014","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"3","key":"10.1016\/j.josat.2023.209175_bb0155","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.drugalcdep.2011.10.004","article-title":"Receipt of opioid agonist treatment in the Veterans Health Administration: Facility and patient factors","volume":"122","author":"Oliva","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.josat.2023.209175_bb0160","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/add.13193","article-title":"Impact of treatment for opioid dependence on fatal drug-related poisoning: A national cohort study in England","volume":"111","author":"Pierce","year":"2016","journal-title":"Addiction"},{"issue":"11","key":"10.1016\/j.josat.2023.209175_bb0170","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1111\/add.14733","article-title":"Buprenorphine prescribing for opioid use disorder in medical practices: Can office-based out-patient care address the opiate crisis in the United States?","volume":"114","author":"Rhee","year":"2019","journal-title":"Addiction"},{"issue":"3","key":"10.1016\/j.josat.2023.209175_bb0175","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/15504263.2017.1325033","article-title":"Trends in opioid use disorder diagnoses and medication treatment among veterans with posttraumatic stress disorder","volume":"13","author":"Shiner","year":"2017","journal-title":"Journal of Dual Diagnosis"},{"year":"2021","series-title":"Stata statistical software: Release 17","author":"StataCorp","key":"10.1016\/j.josat.2023.209175_bb0180"},{"issue":"1\u20133","key":"10.1016\/j.josat.2023.209175_bb0185","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.drugalcdep.2011.10.016","article-title":"The impact of buprenorphine on treatment of opioid dependence in a Medicaid population: Recent service utilization trends in the use of buprenorphine and methadone","volume":"123","author":"Stein","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"author":"Substance Abuse and Mental Health Services Administration","key":"10.1016\/j.josat.2023.209175_bb0190"},{"year":"2021","series-title":"Medications for opioid use disorder. Treatment improvement protocol (TIP) series 63 publication no. PEP21-02-01-002","author":"Substance Abuse and Mental Health Services Administration","key":"10.1016\/j.josat.2023.209175_bb0195"},{"key":"10.1016\/j.josat.2023.209175_bb0200","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jsat.2016.07.010","article-title":"Transitioning from detoxification to substance use disorder treatment: Facilitators and barriers","volume":"70","author":"Timko","year":"2016","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"2","key":"10.1016\/j.josat.2023.209175_bb0205","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1001\/jamapsychiatry.2018.3126","article-title":"Prevention and treatment of opioid misuse and addiction: A review","volume":"76","author":"Volkow","year":"2019","journal-title":"JAMA Psychiatry"},{"issue":"4","key":"10.1016\/j.josat.2023.209175_bb0210","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1046\/j.1365-2710.2002.00430.x","article-title":"Segmented regression analysis of interrupted time series studies in medication use research","volume":"27","author":"Wagner","year":"2002","journal-title":"Journal of Clinical Pharmacy and Therapeutics"},{"issue":"2","key":"10.1016\/j.josat.2023.209175_bb0215","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20622","article-title":"Comparative effectiveness of different treatment pathways for opioid use disorder","volume":"3","author":"Wakeman","year":"2020","journal-title":"JAMA Network Open"},{"issue":"2","key":"10.1016\/j.josat.2023.209175_bb0220","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1080\/08897077.2018.1452327","article-title":"Medications for opioid use disorder in the Department of Veterans Affairs (VA) health care system: Historical perspective, lessons learned, and next steps","volume":"39","author":"Wyse","year":"2018","journal-title":"Substance Abuse"},{"key":"10.1016\/j.josat.2023.209175_bb0225","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.drugalcdep.2019.01.038","article-title":"Predictors of timely opioid agonist treatment initiation among veterans with and without HIV","volume":"198","author":"Wyse","year":"2019","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1016\/j.josat.2023.209175_bb0230","doi-asserted-by":"crossref","first-page":"e2211363","DOI":"10.1001\/jamanetworkopen.2022.11363","article-title":"Comparative effectiveness associated with buprenorphine and naltrexone in opioid use disorder and cooccurring polysubstance use","volume":"5","author":"Xu","year":"2022","journal-title":"JAMA Network Open"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923002266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875923002266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T01:39:36Z","timestamp":1762652376000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875923002266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":45,"alternative-id":["S2949875923002266"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2023.209175","relation":{},"ISSN":["2949-8759"],"issn-type":[{"type":"print","value":"2949-8759"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of an intervention to implement provision of opioid use disorder medication among patients with and without co-occurring substance use disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2023.209175","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"209175"}}